Steph & Co. Has $34,000 Stake in Teleflex Incorporated (NYSE:TFX)

Steph & Co. trimmed its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 73.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 192 shares of the medical technology company’s stock after selling 530 shares during the quarter. Steph & Co.’s holdings in Teleflex were worth $34,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Cromwell Holdings LLC boosted its holdings in Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares during the last quarter. Avior Wealth Management LLC raised its position in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Teleflex in the 3rd quarter valued at approximately $40,000. True Wealth Design LLC boosted its stake in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after acquiring an additional 166 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in Teleflex during the second quarter valued at approximately $42,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Up 2.7 %

NYSE:TFX opened at $181.41 on Friday. The stock has a 50-day simple moving average of $184.42 and a 200 day simple moving average of $215.64. Teleflex Incorporated has a 52-week low of $171.69 and a 52-week high of $256.85. The company has a market cap of $8.42 billion, a PE ratio of 36.06, a PEG ratio of 1.64 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s revenue was up 2.4% compared to the same quarter last year. During the same period last year, the company earned $3.64 earnings per share. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.75%. Teleflex’s dividend payout ratio is 27.04%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Truist Financial reduced their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada lowered their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.